Suicidal behaviors are associated with loneliness and decrease during inpatient CBASP treatment for persistent depressive disorder.


Journal

Journal of psychiatric research
ISSN: 1879-1379
Titre abrégé: J Psychiatr Res
Pays: England
ID NLM: 0376331

Informations de publication

Date de publication:
10 2022
Historique:
received: 09 03 2022
revised: 18 07 2022
accepted: 26 07 2022
pubmed: 9 8 2022
medline: 20 9 2022
entrez: 8 8 2022
Statut: ppublish

Résumé

Suicidal ideation and behavior (SIB) are common in persistent depressive disorder (PDD) and may be related to interpersonal dysfunction. While SIB has been extensively analyzed in other high-risk disorders (e.g., borderline personality disorder, BPD), data on interpersonal risk factors and effects of specific psychotherapy on SIB in PDD are limited. This study aimed at investigating loneliness versus social network size as interpersonal risk factors for SIB in PDD and assess effects of cognitive behavioral analysis system of psychotherapy (CBASP) on this domain. In a prospective naturalistic study, 64 PDD patients were assessed, who underwent a 10-weeks inpatient CBASP program. Our clinical comparison group consisted of 34 BPD patients, who underwent a 10-weeks inpatient dialectical behavioral therapy (DBT) program. SIB was measured with the Columbia-Suicide Severity Rating Scale (C-SSRS), loneliness and social network size with the UCLA Loneliness Scale (UCLA) and the Social Network Index (SNI). Twenty-six PDD patients (40.6% of the PDD sample) showed current SIB at baseline in comparison with 26 BPD patients (76.5% of the BPD sample). While in suicidal PDD patients, SIB was associated with perceived social isolation (UCLA), but not with reduced social network size (SNI), this association was not observed in suicidal BPD patients. In PDD, SIB significantly decreased during CBASP. In conclusion, SIB appears to be associated with interpersonal factors related to loneliness in PDD, but not in BPD. CBASP showed first positive evidence in reducing SIB in PDD, but our pilot data need replication studies.

Identifiants

pubmed: 35939998
pii: S0022-3956(22)00439-3
doi: 10.1016/j.jpsychires.2022.07.059
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

139-144

Informations de copyright

Copyright © 2022 Elsevier Ltd. All rights reserved.

Auteurs

Johannes Wolf (J)

Department for Psychiatry and Psychotherapy, Hospital of the Ludwig-Maximilians-University, Munich, Germany. Electronic address: Johannes.wolf@med.uni-muenchen.de.

Frank Padberg (F)

Department for Psychiatry and Psychotherapy, Hospital of the Ludwig-Maximilians-University, Munich, Germany.

Tabea Nenov-Matt (T)

Department for Psychiatry and Psychotherapy, Hospital of the Ludwig-Maximilians-University, Munich, Germany.

Benedikt L Amann (BL)

Department for Psychiatry and Psychotherapy, Hospital of the Ludwig-Maximilians-University, Munich, Germany; Parc de Salut Mar, Research Unit Centre Forum, IMIM, Univ. Pompeu Fabra, CIBERSAM, Barcelona, Spain.

Barbara B Barton (BB)

Department for Psychiatry and Psychotherapy, Hospital of the Ludwig-Maximilians-University, Munich, Germany.

Jeni Tang (J)

Department for Psychiatry and Psychotherapy, Hospital of the Ludwig-Maximilians-University, Munich, Germany.

Gloria Glessner (G)

Department for Psychiatry and Psychotherapy, Hospital of the Ludwig-Maximilians-University, Munich, Germany.

Eva-Lotta Brakemeier (EL)

Department for Clinical Psychology and Psychotherapy, University Greifswald, Greifswald, Germany.

Andrea Jobst (A)

Department for Psychiatry and Psychotherapy, Hospital of the Ludwig-Maximilians-University, Munich, Germany.

Richard Musil (R)

Department for Psychiatry and Psychotherapy, Hospital of the Ludwig-Maximilians-University, Munich, Germany.

Matthias A Reinhard (MA)

Department for Psychiatry and Psychotherapy, Hospital of the Ludwig-Maximilians-University, Munich, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH